Myeloproliferative Disorders Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Completed
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-24
Mar 24, 2022
C
Recruiting
  • Myelofibrosis
  • +13 more
  • Phoenix, Arizona
  • +54 more
2022-03-04
Mar 4, 2022
H
Not yet recruiting
  • Myeloproliferative Disorders
  • Lymphoproliferative Disorders
  • Blood collection for the evaluation of the anti-drugs sensitivity
  • Pierre-Bénite, France
  • +1 more
2022-03-02
Mar 2, 2022
G
Completed
  • Acute Myeloid Leukemia
  • +3 more
    • (no location specified)
    2022-03-16
    Mar 16, 2022
    H
    Active, not recruiting
    • Myeloid Malignancies
    • +4 more
    • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
    • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    2022-02-25
    Feb 25, 2022
    O
    Enrolling by invitation
    • Acute Leukemia
    • +3 more
    • blood draw, bone marrow procedure, or tissue biopsy
    • Portland, Oregon
      OHSU Knight Cancer Institute
    2022-02-17
    Feb 17, 2022
    C
    Suspended
    • Thrombocytopenia
    • +5 more
    • Thrombosomes
    • Liquid Stored Platelets (LSP)
    • Duarte, California
    • +5 more
    2022-01-13
    Jan 13, 2022
    M
    Active, not recruiting
    • Myeloproliferative Disorders
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2021-11-17
    Nov 17, 2021
    S
    Recruiting
    • Allogeneic Hematopoietic Cell Transplantation (HCT)
    • +5 more
    • Purified regulatory T-cells (Treg) plus CD34+ HSPC
    • +7 more
    • Stanford, California
      Stanford University
    2021-10-28
    Oct 28, 2021
    M
    Withdrawn
    • Acute Myeloid Leukemia
    • +7 more
    • MDG1021 dose 1
    • +3 more
    • Leiden, Zuid Holland, Netherlands
      Leiden University Medical Centre
    2021-09-30
    Sep 30, 2021
    R
    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +3 more
    • standard of care.
    • (no location specified)
    2021-09-14
    Sep 14, 2021
    U
    Terminated
    • Leukemia, Myeloid, Acute
    • +8 more
    • Mesenchymal stem cells
    • Isotonic solution
    • Edeghem, Antwerpen, Belgium
    • +9 more
    2021-08-31
    Aug 31, 2021
    M
    Recruiting
    • Cancer, Metastatic
    • +42 more
    • Clinical Trial Matching
    • New York, New York
      Massive Bio, Inc
    2021-05-21
    May 21, 2021
    M
    Completed
    • Myeloproliferative Disorders
    • +3 more
    • anti-thymocyte globulin
    • +6 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2020-10-30
    Oct 30, 2020
    O
    Completed
    • Myeloproliferative Disorders
    • Pulmonary Hypertension
    • Radiology
    • Odense, Denmark
      Odense University Hospital
    2020-09-15
    Sep 15, 2020
    N
    Completed
    • Primary Myelofibrosis
    • +9 more
    • Camperdown, New South Wales, Australia
    • +17 more
    2020-04-03
    Apr 3, 2020
    S
    Terminated
    • Myeloproliferative Disorders
    • Myeloproliferative Disorders (MPD)
      • Stanford, California
        Stanford University School of Medicine
      2020-04-07
      Apr 7, 2020
      U
      Recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • High dose irradiation conditioning + Treg/Tcon
      • Perugia, PG, Italy
        University of Perugia
      2020-01-08
      Jan 8, 2020
      E
      Completed
      • Neural Tube Defects
      • +5 more
      • CIK cells
      • +4 more
      • Stanford, California
        Stanford University School of Medicine
      2019-04-18
      Apr 18, 2019
      S
      Completed
      • Primary Myelofibrosis
      • Myeloproliferative Disorders
      • Allogeneic hematopoietic stem cell transplantation
      • +4 more
      • Saint-Petersburg, Russian Federation
        First Pavlov State Medical University of St. Petersburg
      2019-04-03
      Apr 3, 2019
      N
      Completed
      • Acute Lymphocytic Leukemia
      • +4 more
      • Isolex 300i Stem Cell Selection
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2018-09-25
      Sep 25, 2018
      I
      Recruiting
      • Acute Leukemia
      • +2 more
      • Blood sampling
      • +3 more
      • Marseille, France
        Institut Paoli-Calmettes
      2018-07-24
      Jul 24, 2018